Trade Akso Health Group - AHG CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.142 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 1.009 |
Open* | 0.998 |
1-Year Change* | 23.67% |
Day's Range* | 0.969 - 1.029 |
52 wk Range | 0.20-1.17 |
Average Volume (10 days) | 677.47K |
Average Volume (3 months) | 3.19M |
Market Cap | 25.02M |
P/E Ratio | -100.00K |
Shares Outstanding | 68.60M |
Revenue | 13.18M |
EPS | -0.58 |
Dividend (Yield %) | N/A |
Beta | 0.54 |
Next Earnings Date | Dec 4, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Oct 3, 2023 | 1.009 | 0.040 | 4.13% | 0.969 | 1.029 | 0.969 |
Oct 2, 2023 | 1.009 | 0.024 | 2.44% | 0.985 | 1.059 | 0.959 |
Sep 29, 2023 | 0.999 | 0.007 | 0.71% | 0.992 | 1.019 | 0.949 |
Sep 28, 2023 | 0.959 | -0.030 | -3.03% | 0.989 | 1.029 | 0.949 |
Sep 27, 2023 | 0.959 | 0.014 | 1.48% | 0.945 | 1.039 | 0.945 |
Sep 26, 2023 | 0.969 | 0.030 | 3.19% | 0.939 | 1.029 | 0.939 |
Sep 25, 2023 | 0.959 | 0.050 | 5.50% | 0.909 | 1.009 | 0.879 |
Sep 22, 2023 | 0.949 | -0.012 | -1.25% | 0.961 | 1.019 | 0.899 |
Sep 21, 2023 | 0.998 | 0.042 | 4.39% | 0.956 | 1.019 | 0.909 |
Sep 20, 2023 | 0.959 | -0.026 | -2.64% | 0.985 | 1.019 | 0.921 |
Sep 19, 2023 | 1.029 | 0.020 | 1.98% | 1.009 | 1.109 | 0.979 |
Sep 18, 2023 | 1.019 | -0.110 | -9.74% | 1.129 | 1.149 | 0.998 |
Sep 15, 2023 | 1.059 | 0.074 | 7.51% | 0.985 | 1.169 | 0.949 |
Sep 14, 2023 | 0.939 | 0.009 | 0.97% | 0.930 | 1.009 | 0.889 |
Sep 13, 2023 | 0.998 | 0.092 | 10.15% | 0.906 | 1.049 | 0.895 |
Sep 12, 2023 | 0.998 | 0.039 | 4.07% | 0.959 | 1.009 | 0.889 |
Sep 11, 2023 | 0.998 | 0.123 | 14.06% | 0.875 | 1.009 | 0.869 |
Sep 8, 2023 | 1.008 | 0.011 | 1.10% | 0.997 | 1.048 | 0.953 |
Sep 7, 2023 | 0.958 | -0.039 | -3.91% | 0.997 | 1.008 | 0.878 |
Sep 6, 2023 | 0.978 | -0.030 | -2.98% | 1.008 | 1.098 | 0.958 |
Akso Health Group Events
Time (UTC) | Country | Event |
---|---|---|
Monday, December 4, 2023 | ||
Time (UTC) 00:30 | Country US
| Event Half Year 2024 Akso Health Group Earnings Release Half Year 2024 Akso Health Group Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total revenue | 13.1816 | 6 | 0 | 6.91447 | 3.69522 |
Revenue | 13.1816 | 6 | 0 | 6.91447 | 3.69522 |
Total Operating Expense | 27.4484 | 9.26046 | 4.24125 | 55.0202 | 10.8844 |
Selling/General/Admin. Expenses, Total | 15.5358 | 3.06146 | 2.08663 | 22.2991 | 10.8844 |
Research & Development | 1.03256 | 0 | |||
Operating Income | -14.2669 | -3.26046 | -4.24125 | -48.1057 | -7.18919 |
Other, Net | 1.20036 | -0.74782 | -0.05208 | 1.23216 | 0.38115 |
Net Income Before Taxes | -13.0665 | -4.00828 | -4.29333 | -46.8735 | -6.80804 |
Net Income After Taxes | -13.084 | -4.1011 | -4.29333 | -47.3635 | -7.61575 |
Net Income Before Extra. Items | -13.1965 | -4.10243 | -4.29333 | -47.3635 | -7.61575 |
Net Income | -1.35992 | -16.8511 | -34.827 | -71.1984 | 5.53258 |
Income Available to Common Excl. Extra. Items | -13.1965 | -4.10243 | -4.29333 | -47.3635 | -7.61575 |
Income Available to Common Incl. Extra. Items | -1.35992 | -16.8511 | -34.827 | -71.1984 | 5.53258 |
Dilution Adjustment | |||||
Diluted Net Income | -1.35992 | -16.8511 | -34.827 | -71.1984 | 5.53258 |
Diluted Weighted Average Shares | 68.5981 | 59.6121 | 48.838 | 48.7572 | 48.6932 |
Diluted EPS Excluding Extraordinary Items | -0.19237 | -0.06882 | -0.08791 | -0.97142 | -0.1564 |
Diluted Normalized EPS | -0.19237 | -0.06882 | -0.08791 | -0.58227 | -0.1564 |
Minority Interest | -0.1125 | -0.00133 | |||
Interest Expense (Income) - Net Operating | 0 | 0.80414 | 2.15462 | 2.49871 | 0 |
Unusual Expense (Income) | 29.1898 | 0 | |||
Total Extraordinary Items | 11.8366 | -12.7486 | -30.5337 | -23.8349 | 13.1483 |
Cost of Revenue, Total | 11.9126 | 5.39487 | 0 | ||
Gross Profit | 1.26899 | 0.60513 | 0 |
Mar 2023 | Sep 2022 | Mar 2022 | Sep 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total revenue | 1.30914 | 11.8724 | 5.75408 | 0.24592 | 0 |
Revenue | 1.30914 | 11.8724 | 5.75408 | 0.24592 | 0 |
Total Operating Expense | 14.5258 | 12.9226 | 0.54471 | 8.71575 | 4.24125 |
Selling/General/Admin. Expenses, Total | 13.3444 | 2.10033 | 0.22 | 2.84146 | 2.08663 |
Research & Development | 0.09108 | -0.24023 | 0.24023 | ||
Interest Expense (Income) - Net Operating | 0 | 0 | 0.20414 | 0.6 | 2.15462 |
Other Operating Expenses, Total | -5.03406 | 5.03406 | |||
Operating Income | -13.2167 | -1.05019 | 5.20937 | -8.46983 | -4.24125 |
Other, Net | -0.68801 | 1.88837 | -0.31943 | -0.42838 | -0.05208 |
Net Income Before Taxes | -13.9047 | 0.83818 | 4.88993 | -8.89821 | -4.29333 |
Net Income After Taxes | -13.9105 | 0.82644 | 4.81502 | -8.91611 | -4.29333 |
Net Income Before Extra. Items | -14.0069 | 0.81034 | 4.81369 | -8.91611 | -4.29333 |
Net Income | -2.17026 | 0.81034 | -7.93495 | -8.91611 | -34.827 |
Income Available to Common Excl. Extra. Items | -14.0069 | 0.81034 | 4.81369 | -8.91611 | -4.29333 |
Income Available to Common Incl. Extra. Items | -2.17026 | 0.81034 | -7.93495 | -8.91611 | -34.827 |
Diluted Net Income | -2.17026 | 0.81034 | -7.93495 | -8.91611 | -34.827 |
Diluted Weighted Average Shares | 68.5981 | 68.5981 | 68.549 | 50.6754 | 48.838 |
Diluted EPS Excluding Extraordinary Items | -0.20419 | 0.01181 | 0.07022 | -0.17595 | -0.08791 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
Diluted Normalized EPS | -0.20419 | 0.01181 | 0.07022 | -0.17595 | -0.08791 |
Unusual Expense (Income) | |||||
Total Extraordinary Items | 11.8366 | -12.7486 | 0 | -30.5337 | |
Cost of Revenue, Total | 1.18137 | 10.7312 | 5.39487 | ||
Gross Profit | 0.12777 | 1.14122 | 0.35921 | ||
Minority Interest | -0.0964 | -0.0161 | -0.00133 | ||
Total Adjustments to Net Income | 0 | 0 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 50.6244 | 30.1225 | 52.0182 | 97.6806 | 163.123 |
Cash and Short Term Investments | 21.9253 | 15.1287 | 6.6681 | 57.3721 | 132.622 |
Cash & Equivalents | 21.9253 | 15.1287 | 6.6681 | 57.3721 | 132.622 |
Total Receivables, Net | 20.0152 | 14.401 | 36.2627 | 36.9735 | 29.2517 |
Prepaid Expenses | 0.88796 | 0.59278 | 0.40082 | 3.33497 | 1.24856 |
Total Assets | 50.6798 | 31.6855 | 80.4762 | 173.256 | 163.89 |
Property/Plant/Equipment, Total - Net | 0.05543 | 0.06689 | 0.76357 | 1.25372 | 0.76709 |
Note Receivable - Long Term | 0 | 1.49612 | 22.3081 | 39.8105 | |
Other Long Term Assets, Total | 3.78633 | 3.72118 | 0 | ||
Total Current Liabilities | 38.3942 | 14.414 | 12.3618 | 26.5627 | 23.8468 |
Accrued Expenses | 1.06905 | 1.14251 | 1.89035 | 2.7911 | 3.78696 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 37.3251 | 3.27146 | 10.4714 | 23.7716 | 20.0598 |
Total Liabilities | 38.3962 | 14.414 | 32.3753 | 46.7527 | 23.8468 |
Total Long Term Debt | 0 | 0 | 20 | 20 | 0 |
Total Equity | 12.2836 | 17.2715 | 48.1009 | 126.503 | 140.043 |
Common Stock | 0.00698 | 0.005 | 0.005 | 0.00496 | 0.0048 |
Additional Paid-In Capital | 71.0219 | 60.6151 | 60.5596 | 59.8069 | 58.418 |
Retained Earnings (Accumulated Deficit) | -53.1077 | -36.2566 | -1.42962 | 69.7688 | 77.2411 |
Other Equity, Total | -1.64922 | -3.10354 | -7.0457 | -1.75696 | 4.37923 |
Total Liabilities & Shareholders’ Equity | 50.6798 | 31.6855 | 80.4762 | 173.256 | 163.89 |
Total Common Shares Outstanding | 68.5981 | 48.8506 | 48.8183 | 49.2041 | 15.986 |
Accounts Receivable - Trade, Net | 0.01525 | 0.02836 | 0.00188 | 0.41864 | |
Property/Plant/Equipment, Total - Gross | 0.14131 | 0.13197 | 0.80927 | 1.99927 | |
Accumulated Depreciation, Total | -0.08588 | -0.06508 | -0.0457 | -0.74555 | |
Long Term Investments | 0 | 1.6 | 30.7898 | ||
Long Term Debt | 0 | 20 | 20 | ||
Other Liabilities, Total | 0 | 0.0135 | 0.18996 | ||
Treasury Stock - Common | -3.98837 | -3.98837 | -3.98837 | -1.32047 | |
Other Current Assets, Total | 0 | 8.68651 | |||
Current Port. of LT Debt/Capital Leases | 0 | 10 | 0 | ||
Total Inventory | 7.79582 | ||||
Minority Interest | 0.00198 |
Sep 2022 | Mar 2022 | Sep 2021 | Mar 2021 | Sep 2020 | |
---|---|---|---|---|---|
Total Current Assets | 20.871 | 50.6244 | 22.3104 | 30.1225 | 47.8994 |
Cash and Short Term Investments | 9.99056 | 21.9253 | 15.4568 | 15.1287 | 21.9013 |
Cash & Equivalents | 9.99056 | 21.9253 | 15.4568 | 15.1287 | 21.9013 |
Total Receivables, Net | 7.92858 | 20.0152 | 6.56152 | 14.3892 | 18.2805 |
Accounts Receivable - Trade, Net | 7.92858 | 0.01525 | 0.01776 | 0.02836 | 0.28878 |
Prepaid Expenses | 2.05229 | 0.88796 | 0.29201 | 0.60452 | 0.71759 |
Total Assets | 20.9073 | 50.6798 | 32.5244 | 31.6855 | 60.181 |
Property/Plant/Equipment, Total - Net | 0.03631 | 0.05543 | 0.06881 | 0.06689 | 0.07214 |
Long Term Investments | 0 | 1.6 | |||
Note Receivable - Long Term | 0 | 0 | 1.49612 | 10.6095 | |
Other Long Term Assets, Total | 10.1453 | 0 | |||
Total Current Liabilities | 10.9772 | 38.3942 | 12.9722 | 14.414 | 13.1289 |
Accrued Expenses | 1.18238 | 1.06905 | 0.945 | 1.14251 | 1.35086 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 9.79486 | 37.3251 | 2.02725 | 3.27146 | 11.7781 |
Total Liabilities | 10.9944 | 38.3962 | 12.9722 | 14.414 | 33.1289 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 20 |
Long Term Debt | 0 | 20 | |||
Other Liabilities, Total | 0 | 0 | |||
Total Equity | 9.91285 | 12.2836 | 19.5522 | 17.2715 | 27.052 |
Common Stock | 0.00698 | 0.00698 | 0.00698 | 0.005 | 0.005 |
Additional Paid-In Capital | 71.0219 | 71.0219 | 71.0219 | 60.6151 | 60.6151 |
Retained Earnings (Accumulated Deficit) | -52.2973 | -53.1077 | -45.1727 | -36.2566 | -25.0173 |
Treasury Stock - Common | -3.98837 | -3.98837 | -3.98837 | -3.98837 | -3.98837 |
Other Equity, Total | -4.83032 | -1.64922 | -2.31557 | -3.10354 | -4.56238 |
Total Liabilities & Shareholders’ Equity | 20.9073 | 50.6798 | 32.5244 | 31.6855 | 60.181 |
Total Common Shares Outstanding | 68.5981 | 68.5981 | 68.5981 | 48.8506 | 48.8572 |
Other Current Assets, Total | 0 | 7.00003 | |||
Current Port. of LT Debt/Capital Leases | 0 | 10 | 10 | ||
Total Inventory | 0.89956 | 7.79582 | |||
Minority Interest | 0.01721 | 0.00198 | |||
Property/Plant/Equipment, Total - Gross | 0.12593 | ||||
Accumulated Depreciation, Total | -0.08962 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -16.8497 | -31.5522 | -47.3635 | 5.53258 | 65.5106 |
Cash From Operating Activities | -8.62837 | 10.0585 | -58.2787 | -1.73108 | 87.723 |
Cash From Operating Activities | 0.01839 | 0.01516 | 0.12052 | 0.4068 | 0.17438 |
Deferred Taxes | 0 | 0 | 3.3083 | -3.72408 | 0.41562 |
Changes in Working Capital | -2.56415 | 23.2255 | -32.9 | -11.6206 | 19.7935 |
Cash From Investing Activities | -19.9639 | -0.00066 | 12.7754 | -68.1066 | -27.6238 |
Capital Expenditures | -0.00486 | 0 | -0.20036 | -0.94481 | -0.45603 |
Cash From Financing Activities | 34.7811 | -9.03722 | -1.55219 | -0.02938 | 47.5163 |
Financing Cash Flow Items | 10.0172 | 0.03694 | 7.36367 | -0.318 | 4.24256 |
Issuance (Retirement) of Stock, Net | 0 | 0.00001 | -2.26261 | -0.16385 | 43.2737 |
Foreign Exchange Effects | 0.60772 | 3.18293 | 0.60864 | -5.38333 | 5.77472 |
Net Change in Cash | 6.7966 | 4.20351 | -46.4469 | -75.2503 | 113.39 |
Non-Cash Items | 10.7671 | 18.3701 | 18.556 | 7.67422 | 1.82887 |
Cash Taxes Paid | 0.03862 | 0.00976 | 3.20938 | 12.2482 | 1.01696 |
Other Investing Cash Flow Items, Total | -19.959 | -0.00066 | 12.9757 | -67.1617 | -27.1678 |
Total Cash Dividends Paid | 0 | 0 | -19.5475 | ||
Issuance (Retirement) of Debt, Net | 24.7639 | -9.07416 | -6.65324 | 20 |
Sep 2022 | Mar 2022 | Sep 2021 | Mar 2021 | Sep 2020 | |
---|---|---|---|---|---|
Net income/Starting Line | 0.82644 | ||||
Cash From Operating Activities | -1.33412 | ||||
Cash From Operating Activities | 0.01384 | ||||
Non-Cash Items | 0 | ||||
Changes in Working Capital | -2.17439 | ||||
Cash From Investing Activities | 20 | ||||
Other Investing Cash Flow Items, Total | 20 | ||||
Cash From Financing Activities | -27.5138 | ||||
Financing Cash Flow Items | -27.5138 | ||||
Foreign Exchange Effects | -3.0868 | ||||
Net Change in Cash | -11.9348 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Renaissance Technologies LLC | Hedge Fund | 0.8998 | 214398 | -19300 | 2023-06-30 | HIGH |
Two Sigma Investments, LP | Hedge Fund | 0.4789 | 114093 | -6920 | 2023-06-30 | HIGH |
Rhumbline Advisers Ltd. Partnership | Investment Advisor | 0.0837 | 19940 | 19940 | 2023-06-30 | LOW |
HRT Financial LP | Investment Advisor | 0.0423 | 10073 | 10073 | 2023-06-30 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 0.0141 | 3370 | 0 | 2023-06-30 | MED |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Akso Health Group Company profile
About Akso Health Group - ADR
Akso Health Group, formerly Xiaobai Maimai Inc, is a China-based company mainly engaged in e-commerce business. The Company provides services through the Xiaobai Maimai application (APP), a one-stop e-commerce platform. The Company provides products covering food and beverage, wine, cosmetic products, fashion and apparel, entertainment, houseware, home appliances and others.
Financial summary
BRIEF: For the six months ended 30 September 2021, AksoHealth Group - ADR revenues decreased 82% to $246K. Netloss before extraordinary items decreased 49% to $8.9M.Revenues reflect Interest income decrease of 82% to $187K,Commission services decrease of 81% to $60K. Lower net lossreflects Provision for uncollectable loans receiv decreaseof 61% to $5M (expense), General and administrativedecrease of 25% to $2.3M (expense).
Industry: | E-commerce & Auction Services |
Room 515, Floor 5, Jia No. 92-4 To 24
Jianguo Road Chaoyang Dist
BEIJING
BEIJING 100020
CN
Income Statement
- Annual
- Quarterly
News

How to Trade The Triple Top
Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.
14:13, 27 September 2023
Q4 lookahead: US indices starting to show signs of trouble?
US indices start to draw attention as traders focus on the outlook for Q4.
07:20, 27 September 2023
USD/JPY Climbs Towards Key Highs
USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.
11:32, 26 September 2023
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com